Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1995-2-16
pubmed:abstractText
Early exposure to cow milk proteins was linked to the development of type I diabetes by consistent epidemiology, and by feeding and tolerization studies in diabetes-prone rodents. Dietary BSA was suggested as the culprit because patients and relevant rodents have elevated anti-BSA Abs that precipitate the recently cloned protein, p69, from beta cell lysates. A total of 68 of 78 children with recent onset diabetes had BSA-reactive T cells at the time of diagnosis. Here we 1) map the fine specificity of these T cells, 2) delineate a homologous peptide sequence near the N-terminus of p69, and 3) demonstrate T cell recognition of this p69 sequence (T cell epitope p69, Tep69) by patient T cells. The Tep69 sequence is conserved in p69 of patients and diabetes-prone rodents. Whereas BSA triggers T cell proliferation, recombinant p69 and a synthetic Tep69 peptide induce early stages of T cell activation (IL-2R transcription) but insufficient IL-2 production and thus anergy. Exogenous IL-2 overrides anergy and allows proliferative expansion of p69-responsive T cells. In mixing experiments, p69 and Tep69 peptide prevented proliferative responses to BSA even at 100-fold smaller concentrations. These findings imply that high-affinity self-peptide triggers anergy, whereas low-affinity mimicry Ag triggers proliferative expansion of these T cells. This implies a disease model in which mimicry Ag would rescue autoreactive cells from ablation by self-Ag.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0022-1767
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
154
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1461-9
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:7822811-Adolescent, pubmed-meshheading:7822811-Amino Acid Sequence, pubmed-meshheading:7822811-Autoantigens, pubmed-meshheading:7822811-Base Sequence, pubmed-meshheading:7822811-Blotting, Western, pubmed-meshheading:7822811-Child, pubmed-meshheading:7822811-Clonal Anergy, pubmed-meshheading:7822811-Cross Reactions, pubmed-meshheading:7822811-Diabetes Mellitus, Type 1, pubmed-meshheading:7822811-Female, pubmed-meshheading:7822811-Humans, pubmed-meshheading:7822811-Islets of Langerhans, pubmed-meshheading:7822811-Lymphocyte Activation, pubmed-meshheading:7822811-Male, pubmed-meshheading:7822811-Molecular Sequence Data, pubmed-meshheading:7822811-Receptors, Interleukin-2, pubmed-meshheading:7822811-Recombinant Proteins, pubmed-meshheading:7822811-Serum Albumin, Bovine, pubmed-meshheading:7822811-T-Lymphocytes, pubmed-meshheading:7822811-Transcription, Genetic
pubmed:year
1995
pubmed:articleTitle
T cell activation and anergy to islet cell antigen in type I diabetes.
pubmed:affiliation
Hospital For Sick Children, Research Institute, University of Toronto, Ontario, Canada.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't